Gut commensalism, cytokines, and central nervous system demyelination

Journal of Interferon and Cytokine Research

Volumn 34, Issue 8, 2014, Pages 605-614

  Telesford, Kiel ^a   Ochoa Repáraz, Javier ^b   Kasper, Lloyd H ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TRANSCRIPTION FACTOR FOXP3;

B LYMPHOCYTE; CELL ACTIVITY; CELL POPULATION; COMMENSALISM; COMPARATIVE STUDY; DEMYELINATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HELMINTH; HELPER CELL; HUMAN; LYMPHOCYTE FUNCTION; MICROBIOME; MICROFLORA; MULTIPLE SCLEROSIS; NONHUMAN; POLARIZATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; ANIMAL; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; INTESTINE; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; MUCOSAL IMMUNITY; SYMBIOSIS; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; B-LYMPHOCYTES; CENTRAL NERVOUS SYSTEM; CYTOKINES; DEMYELINATING DISEASES; HUMANS; IMMUNE TOLERANCE; IMMUNITY, MUCOSAL; INTESTINES; LYMPHOCYTE ACTIVATION; MICROBIOTA; SYMBIOSIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84905390211     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2013.0134     Document Type: Review

References (84)

1. Afzali B, Mitchell PJ, Edozie FC, Povoleri GAM, Dowson SE, Demandt L, Walter G, Canavan JB, Scotta C, Menon B, Chana PS, Khamri W, Kordasti SY, Heck S, Grimbacher B, Tree T, Cope AP, Taams LS, Lechler RI, John S, Lombardi G. 2013. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner. Eur J Immunol 43(8):2043-2054.
2. Agrawal S, Gupta S. 2011. TLR1/2, TLR7, and TLR9 signals directly activate human peripheral blood naive and memory B cell subsets to produce cytokines, chemokines, and he-matopoietic growth factors. J Clin Immunol 31(1):89-98.
3. Aharoni R, Kayhan B, Eilam R, Sela M, Arnon R. 2003. Gla-tiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ. Proc Natl Acad Sci USA 100(24):14157-14162.
4. Aharoni R, Teitelbaum D, Sela M, Arnon R. 1997. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encepha-lomyelitis. Proc Natl Acad Sci USA 94(20):10821-10826.
5. Alexander J, Harris M, Wells S, Mills G, Chalamidas K, Ganta V, McGee J, Jennings M, Gonzalez-Toledo E, Minagar A. 2010. Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-1b. Mult Scler J 16(7):801-809.
6. Appel H, Neure L, Kuhne M, Braun J, Rudwaleit M, Sieper J. 2004. An elevated level of IL-10-and TGFbeta-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis. Clin Rheumatol 23(5):435-440.
7. Araujo MI, Lopes AA, Medeiros M, Cruz AA, Sousa-Atta L, Solé D, Carvalho EM. 2000. Inverse association between skin response to aeroallergens and Schistosoma mansoni infection. Int Arch Allergy Immunol 123(2):145-148.
8. Asano M, Toda M, Sakaguchi N, Sakaguchi S. 1996. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 184(2):387-396.
9. Astier AL, Meiffren G, Freeman S, Hafler DA. 2006. Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 116(12):3252-3257.
10. Barr TA, Shen P, Brown S, Lampropoulou V, Roch T, Lawrie S, Fan B, O'Connor RA, Anderton SM, Bar-Or A, Fillatreau S, Gray D. 2012. B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6-producing B cells. J Exp Med 209(5):1001-1010.
11. Begum-Haque S, Sharma A, Christy M, Lentini T, Ochoa-Repáraz J, Fayed IF, Mielcarz D, Haque A, Kasper LH. 2010. Increased expression of B cell-associated regulatory cytokines by glatiramer acetate in mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 219(1-2):47-53.
12. Begum-Haque S, Sharma A, Kasper IR, Foureau DM, Mielcarz DW, Haque A, Kasper LH. 2008. Downregulation of IL-17 and IL-6 in the central nervous system by glatiramer acetate in experimental autoimmune encephalomyelitis. J Neuro-immunol 204(1-2):58-65.
13. Berer K, Mues M, Koutrolos M, Al Rasbi Z, Boziki M, Johner C, Wekerle H, Krishnamoorthy G. 2012. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479(7374):538-541.
14. Booth NJ, McQuaid AJ, Sobande T, Kissane S, Agius E, Jackson SE, Salmon M, Falciani F, Yong K, Rustin MH, Akbar AN, Vukmanovic-Stejic M. 2010. Different prolifer-ative potential and migratory characteristics of human CD4 + regulatory T cells that express either CD45RA or CD45RO. J Immunol 184(8):4317-4326.
15. Cooke A, Tonks P, Jones FM, O'Shea H, Hutchings P, Fulford AJ, Dunne DW. 1999. Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol 21(4):169-176.
16. Correale J, Farez M. 2007. Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 61(2):97-108.
17. Correale J, Farez M, Razzitte G. 2008. Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 64(2):187-199.
18. Correale J, Farez MF. 2011. The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 233(1-2): 6-11.
19. Cross AH, Stark JL, Lauber J, Ramsbottom MJ, Lyons J-A. 2006. Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 180(1-2):63-70.
20. Duddy M, Niino M, Adatia F, Hebert S, Freedman M, Atkins H, Kim HJ, Bar-Or A. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 178(10):6092-6099.
21. Durelli L, Conti L, Clerico M, Boselli D, Contessa G, Ripellino P, Ferrero B, Eid P, Novelli F. 2009. T-helper 17 cells expand in multiple sclerosis and are inhibited by interferon-b. Ann Neurol 65(5):499-509.
22. Elliott DE, Li J, Blum A, Metwali A, Qadir K, Urban JF, Jr., Weinstock JV. 2003. Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol 284(3):G385-G391.
23. Fleming J, Isaak A, Lee J, Luzzio C, Carrithers M, Cook T, Field A, Boland J, Fabry Z. 2011. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler J 17(6):743-754.
24. Fletcher JM, Lonergan R, Costelloe L, Kinsella K, Moran B, O'Farrelly C, Tubridy N, Mills KHG. 2009. CD39 +Foxp3 + regulatory T cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 183(11):7602-7610.
25. Fritz JH, Rojas OL, Simard N, McCarthy DD, Hapfelmeier S, Rubino S, Robertson SJ, Larijani M, Gosselin J, Ivanov II, Martin A, Casellas R, Philpott DJ, Girardin SE, McCoy KD, Macpherson AJ, Paige CJ, Gommerman JL. 2013. Acquisition of a multifunctional IgA + plasma cell phenotype in the gut. Nature 481(7380):199-203.
26. Fritzsching B, Oberle N, Pauly E, Geffers R, Buer J, Poschl J, Krammer P, Linderkamp O, Suri-Payer E. 2006. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 108(10):3371-3378.
27. Gran B, Zhang G-X, Yu S, Li J, Chen X-H, Ventura ES, Kamoun M, Rostami A. 2002. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 169(12):7104-7110.
28. Gruden-Movsesijan AN, Mostaricia-Stojkovic N, Stosic-grujicic S, Milic M, Sofronic-Milosavljevic L. 2010. Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats. Parasite Immunol 32(6):450-459.
29. Haas J, Fritzsching B, Trübswetter P, Korporal M, Milkova L, Fritz B, Vobis D, Krammer PH, Suri-Payer E, Wildemann B. 2007. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 179(2):1322-1330.
30. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PIW, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, Rioux JD, McCauley JL, Haines JL, Barcellos LF, Cree B, Oksenberg JR, Hauser SL. 2007. Risk alleles for multiple sclerosis identified by a gen-omewide study. N Engl J Med 357(9):851-862.
31. Harp CT, Ireland S, Davis LS, Remington G, Cassidy B, Cravens PD, Stüve O, Lovett-Racke AE, Eagar TN, Greenberg BM, Racke MK, Cowell LG, Karandikar NJ, Frohman EM, Monson NL. 2010. Memory B cells from a subset of treatment-naïve relapsing-remitting multiple sclerosis patients elicit CD4 + T-cell proliferation and IFN-g production in response to myelin basic protein and myelin oligodendrocyte glycoprotein. Eur J Immunol 40(10):2942-2956.
32. Hirotani M, Niino M, Fukazawa T, Kikuchi S, Yabe I, Hamada S, Tajima Y, Sasaki H. 2010. Decreased IL-10 production mediated by Toll-like receptor 9 in B cells in multiple sclerosis. J Neuroimmunol 221(1-2):95-100.
33. Hong J, Li N, Zhang X, Zheng B, Zhang JZ. 2005. Induction of CD4 + CD25 + regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc Natl Acad Sci USA 102(18):6449-6454.
34. Hooper LV. 2004. Bacterial contributions to mammalian gut development. Trends Microbiol 12(3):129-134.
35. Hug A, Korporal M, Schröder I, Haas J, Glatz K, Storch-Hagenlocher B, Wildemann B. 2003. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol 171(1):432-437.
36. Huttenhower C. 2012. Structure, function and diversity of the healthy human microbiome. Nature 486(7402):207-214.
37. Ito N, Boppana S, Huang H, Dhib-Jalbut S, Ito K. 2011. Gastrointestinal tract is the place where encephalitogenic T cells develop in the spontaneous EAE mice [Abstract]. J Immunol 186:101.11.
38. Ito T, Hanabuchi S, Wang Y-H, Park WR, Arima K, Bover L, Qin FX-F, Gilliet M, Liu Y-J. 2008. Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery. Immunity 28(6):870-880.
39. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139(3):485-498.
40. Jee Y, Piao WH, Liu R, Bai XF, Rhodes S, Rodebaugh R, Campagnolo DI, Shi FD, Vollmer TL. 2007. CD4(+) CD25( + ) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin Immunol 125(1):34-42.
41. Jun S, Ochoa-Repáraz J, Zlotkowska D, Hoyt T, Pascual DW. 2012. Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-b. J Neuroimmunol 245(1-2):39-47.
42. Kala M, Rhodes SN, Piao W-H, Shi F-D, Campagnolo DI, Vollmer TL. 2010. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis. Exp Neurol 221(1):136-145.
43. Kamada N, Seo SU, Chen GY, Nunez G. 2013. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13(5):321-335.
44. Kitagaki K, Businga TR, Racila D, Elliott DE, Weinstock JV, Kline JN. 2006. Intestinal helminths protect in a murine model of asthma. J Immunol 177(3):1628-1635.
45. Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. 2011. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J Neuroimmunol 239(1-2):80-86.
46. Kreisman LSC, Cobb BA. 2011. Glycoantigens induce human peripheral Tr1 cell differentiation with gut-homing specialization. J Biol Chem 286(11):8810-8818.
47. Lavasani S, Dzhambazov B, Nouri M, Fåk F, Buske S, Molin G, Thorlacius H, Alenfall J, Jeppsson B, Weström B. 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS ONE 5(2):e9009.
48. Lee YK, Menezes JS, Umesaki Y, Mazmanian SK. 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 108(Suppl. 1):4615-4622.
49. Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, Langer-Gould A, Strober S, Cannella B, Allard J, Klo-nowski P, Austin A, Lad N, Kaminski N, Galli SJ, Oksenberg JR, Raine CS, Heller R, Steinman L. 2002. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med 8(5): 500-508.
50. Macpherson AJ, Harris NL. 2004. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4(6):478-485.
51. Matsushita T, Yanaba K, Bouaziz J-D, Fujimoto M, Tedder TF. 2008. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118(10):3420-3430.
52. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122(1): 107-118.
53. Mazmanian SK, Round JL, Kasper DL. 2008. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453(7195):620-625.
54. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. 2009. Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 30(6):899-911.
55. Nepom GT. 2005. Tetramer analysis of human autoreactive CD4-positive T cells. Adv Immunol 88:51-71.
56. Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, Wekerle H, Hohlfeld R. 2000. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc Natl Acad Sci USA 97(13):7452-7457.
57. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. 2000. Multiple sclerosis. N Engl J Med 343(13):938-952.
58. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. 2010a. Central nervous system demyelinating disease protection by the human commensal bacteroides fragilis depends on poly-saccharide A expression. J Immunol 185(7):4101-4108.
59. Ochoa-Repáraz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, Kasper LH. 2009. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol 183(10):6041-6050.
60. Ochoa-Repáraz J, Mielcarz DW, Haque-Begum S, Kasper LH. 2010b. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 1(2):103-108.
61. Ochoa-Repáraz J, Mielcarz DW, Wang Y, Begum-Haque S, Dasgupta S, Kasper DL, Kasper LH. 2010c. A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease. Mucosal Immunol 3(5):487-495.
62. Ochoa-Repáraz J, Riccardi C, Rynda A, Jun S, Callis G, Pascual DW. 2007. Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyeli-tis. J Immunol 178(3):1791-1799.
63. Panitch HS, Hirsch RL, Schindler J, Johnson KP. 1987. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Am Acad Neurol 37(7):1097-1102.
64. Pesenacker AM, Bending D, Ursu S, Wu Q, Nistala K, Wed-derburn LR. 2013. CD161 defines the subset of FoxP3 + T cells capable of producing proinflammatory cytokines. Blood 121(14):2647-2658.
65. Peters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, Wucherpfennig K, Turley S, Carroll MC, Sobel RA, Bettelli E, Kuchroo VK. 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35(6):986-996.
66. Pistoia V. 1997. Production of cytokines by human B cells in health and disease. Immunol Today 18(7):343-350.
67. Ramgolam VS, Sha Y, Marcus KL, Choudhary N, Troiani L, Chopra M, Markovic-Plese S. 2011. B cells as a therapeutic target for IFN-b in relapsing-remitting multiple sclerosis. J Immunol 186(7):4518-4526.
68. Rubio JP, Stankovich J, Field J, Tubridy N, Marriott M, Chapman C, Bahlo M, Perera D, Johnson LJ, Tait BD, Varney MD, Speed TP, Taylor BV, Foote SJ, Butzkueven H, Kilpatrick TJ. 2008. Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians. Genes Immun 9(7):624-630.
69. Sakaguchi S, Miyara M, Costantino CM, Hafler DA. 2010. FOXP3 + regulatory T cells in the human immune system. Nat Rev Immunol 10(7):490-500.
70. Segal BM, Constantinescu CS, Raychaudhuri A, Kim L, Fide-lus-Gort R, Kasper LH. 2008. Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study. Lancet Neurol 7(9):796-804.
71. Sewell D, Qing Z, Reinke E, Elliot D, Weinstock J, Sandor M, Fabry Z. 2003. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 15(1):59-69.
72. Sommer F, Bäckhed F. 2013. The gut microbiota-masters of host development and physiology. Nat Rev Microbiol 11(4): 227-238.
73. Sospedra M, Martin R. 2005. Immunology of multiple sclerosis. Annu Rev Immunol 23(1):683-747.
74. Surana NK, Kasper DL. 2011. The yin yang of bacterial poly-saccharides: lessons learned from B. fragilis PSA. Immunol Rev 245(1):13-26.
75. Traggiai E, Biagioli T, Rosati E, Ballerini C, Mazzanti B, Ben-Nun A, Massacesi L, Vergelli M. 2001. IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis. J Neu-roimmunol 121(1-2):111-119.
76. Venken K, Hellings N, Broekmans T, Hensen K, Rummens J-L, Stinissen P. 2008a. Natural naive CD4+CD25+ CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol 180(9):6411-6420.
77. Venken K, Hellings N, Liblau R, Stinissen P. 2010. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol Med 16(2):58-68.
78. Venken K, Hellings N, Thewissen M, Somers V, Hensen K, Rummens J-L, Medaer R, Hupperts R, Stinissen P. 2008b. Compromised CD4 +CD25 highregulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level. Immunology 123(1):79-89.
79. Viglietta V. 2004. Loss of functional suppression by CD4 + CD25 + regulatory T cells in patients with multiple sclerosis. J Exp Med 199(7):971-979.
80. Walsh KP, Brady MT, Finlay CM, Boon L, Mills KHG. 2009. Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183(3):1577-1586.
81. Wilson MS, Taylor MD, O'Gorman MT, Balic A, Barr TA, Filbey K, Anderton SM, Maizels RM. 2010. Helminth-induced CD19+ CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol 40(6):1682-1696.
82. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA. 1994. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179(3):973-984.
83. Zheng X, Hu X, Zhou G, Lu Z, Qiu W, Bao J, Dai Y. 2008. Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response. J Neu-roimmunol 194(1-2):107-114.
84. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu Rev Immunol 28(1):445-489.